NEW YORK, Dec. 19 (GenomeWeb News) - Genedata has extended an agreement with Roche to deploy its Screener software at all of Roche's high-throughput screening facilities in North America and Europe, Genedata said today.
Under the terms of the original agreement, Roche used Genedata's software at its Basel, Switzerland-facility. The agreement expands the collaboration to include more facilities over several years.
Roche Scientists use Screener to estimate the biological potency of thousands of compounds, Genedata said.
The software has been already deployed to four sites in "a very short time period," Genedata said.